top of page

Sep 4th, 2024

The Scientist Interview

Our lab’s research has been featured in the latest issue of The Scientist Digest. See The Scientist Interview.

June 28th, 2024

New R01 grant from NICHD

We are grateful to the National Institute of Child Health and Human Development for supporting our studies on the mechanisms of enhancer mutations in congenital limb disorders over the next five years. See the UCI press release.

May 27th, 2024

New preprint

We are happy to share our new work Conserved Cis-Acting Range Extender Element Mediates Extreme Long-Range Enhancer Activity in Mammals. Huge congratulations to our PhD student Grace who led the project! See Papers.

March 20th, 2024

New paper is out

Our preprint characterizing mouse developmental enhancer—promoter interaction is published in Nature Genetics. Congratulations to our postdoc Zhuoxin Chen who led the study! See Papers.

December 11, 2023

New preprint

We are happy to share our new work Rapid and Quantitative Functional Interrogation of Human Enhancer Variant Activity in Live Mice. Huge congratulations to our MD/PhD student Ethan who led the project! See Papers.

March 3, 2023

Grace receives NIH F31 fellowship

Congratulations to our CMB graduate student Grace Bower, who has been awarded an NIH F31 – Ruth L. Kirschstein National Research Service Award from NICHD. Well done!

November 20, 2022

New preprint is out

We are happy to share our new preprint Widespread Increase in Enhancer-Promoter Interactions during Developmental Enhancer Activation in Mammals. Huge congratulations to our postdoc Zhuoxin Chen who led the study! See Papers.

October 6th, 2022

New grant

The Kvon lab has received NIH Director’s New Innovator Award. The grant will support our studies on long-range gene regulation over the next 5 years. See UCI press release.

Research Interests

Specific non-coding regulatory DNA elements called enhancers regulate gene transcription during animal development. The Kvon lab investigates transcriptional regulation by enhancers using cutting-edge genomics, genome editing, and transgenic tools. We are particularly interested in studying the role of enhancers in development and evolution and how enhancer malfunction leads to congenital disease.  

News

bottom of page